- Home
- SRTS vs GNTA Comparison
SRTS vs GNTA Comparison
Compare SRTS & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRTS
- GNTA
- Stock Information
- Founded
- SRTS 2010
- GNTA 2014
- Country
- SRTS United States
- GNTA Italy
- Employees
- SRTS N/A
- GNTA N/A
- Industry
- SRTS Medical/Dental Instruments
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SRTS Health Care
- GNTA Health Care
- Exchange
- SRTS Nasdaq
- GNTA Nasdaq
- Market Cap
- SRTS 77.9M
- GNTA 81.2M
- IPO Year
- SRTS 2016
- GNTA 2021
- Fundamental
- Price
- SRTS $4.16
- GNTA $3.91
- Analyst Decision
- SRTS Strong Buy
- GNTA Strong Buy
- Analyst Count
- SRTS 3
- GNTA 1
- Target Price
- SRTS $11.67
- GNTA $25.00
- AVG Volume (30 Days)
- SRTS 56.1K
- GNTA 28.7K
- Earning Date
- SRTS 08-07-2025
- GNTA 01-01-0001
- Dividend Yield
- SRTS N/A
- GNTA N/A
- EPS Growth
- SRTS N/A
- GNTA N/A
- EPS
- SRTS 0.11
- GNTA N/A
- Revenue
- SRTS $39,488,000.00
- GNTA N/A
- Revenue This Year
- SRTS $4.33
- GNTA N/A
- Revenue Next Year
- SRTS $31.55
- GNTA N/A
- P/E Ratio
- SRTS $38.07
- GNTA N/A
- Revenue Growth
- SRTS 24.75
- GNTA N/A
- 52 Week Low
- SRTS $4.01
- GNTA $2.74
- 52 Week High
- SRTS $9.33
- GNTA $7.28
- Technical
- Relative Strength Index (RSI)
- SRTS 28.08
- GNTA 55.67
- Support Level
- SRTS $4.45
- GNTA $3.69
- Resistance Level
- SRTS $4.81
- GNTA $3.94
- Average True Range (ATR)
- SRTS 0.19
- GNTA 0.29
- MACD
- SRTS -0.05
- GNTA 0.10
- Stochastic Oscillator
- SRTS 0.00
- GNTA 92.06
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.